Document is current
Any future updates will be listed below
-
Authors
Harigai, Masayoshi https://orcid.org/0000-0002-6418-2603
Sugihara, Takahiko https://orcid.org/0000-0002-7181-7494
- License Information
-
More Information
Article History
Accepted: 18 February 2025
First Online: 9 April 2025
Declarations
:
: M.H. has received research grants from AbbVie Japan GK, Asahi Kasei Corp., Ayumi Pharmaceutical Co., Boehringer Ingelheim Japan, Inc., Bristol Myers Squibb Co., Ltd., Chugai Pharmaceutical Co., Eisai Co., Ltd., Eli Lilly Japan K.K., Kaken Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., Mochida Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Nippon Shinyaku Co., Ltd., Pfizer Japan Inc., Taisho Pharmaceutical Co., Ltd., Teijin Pharma Ltd., UCB Japan Co., Ltd. and Viatris Japan; has received speaker’s fees from AbbVie Japan GK, Asahi Kasei Corp., Astra Zeneca K. K., Ayumi Pharmaceutical Co., Boehringer Ingelheim Japan, Inc., Bristol Myers Squibb Co., Ltd., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., GlaxoSmithKline K.K., Gilead Sciences Inc., Janssen Pharmaceutical K.K., Kissei Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., Mochida Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Pfizer Japan Inc., Taisho Pharmaceutical Co., Ltd. and Teijin Pharma Ltd; and is a consultant for AbbVie, Boehringer-Ingelheim, Bristol Myers Squibb Co., Kissei Pharmaceutical Co., Ltd. and Teijin Pharma. T.S. has received research grants from Asahi KASEI Co., Ltd., Daiichi Sankyo., Chugai Pharmaceutical Co., Ltd., and Ono Pharmaceutical. TS has received honoraria from AbbVie Japan Co., Ltd., Asahi KASEI Co., Ltd., Astellas Pharma Inc., Ayumi Pharmaceutical, Bristol Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Mitsubishi-Tanabe Pharma Co., Ono Pharmaceutical, Pfizer Japan Inc. and Taisho Pharmaceutical Co., Ltd.
: Not applicable.
: No funding was received for this work.
: Not applicable.
: Not applicable.
: Not applicable.
: M.H. conceived the manuscript. M.H. and T.S. drafted and reviewed the manuscript critically for important intellectual content and approved the final version to be published. M.H. and T.S. have agreed to be accountable for all scientific aspects of the manuscript, ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
